Drug Database
Back to search

Poland· PL-100513133

Beloderm

A betamethasone product containing betamethasonum, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 14 of our 19 countries.

ATC D07AC01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBelodermATCD07AC01REGISTER NO.PL-100513133PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about betamethasonumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Betamethasone is registered in 14 of 19 countries.

Countries holding a registration under ATC D07AC01 (betamethasone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search betamethasone products by name

Betamethasone · ATC D07AC01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Betamethasonum
Manufacturer
Medezin Sp. z o.o.
Country
Poland (PL)
ATC code
D07AC01
ATC class
Betamethasone
Defined daily dose
2 mg, T
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991565060

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

55 interactions on record for betamethasone.

Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check betamethasone against other medicinesHow interaction checks work

Betamethasone · interactions on record

55 records

  • 55 minor

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Betamethasone in 17 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All betamethasone products

    Authorised across Europe · EMA

    The same active substance is authorised in 29 EEA countries. Names it is sold under:

    • Austria · Betnesol, Betnovate
    • Belgium · Betnelan V, Celestone
    • Bulgaria · Бетазон, Бетазонтаб
    • Cyprus · Betnovate, Medobeta
    • Czechia · Beloderm, Diprosone
    • Germany · Betagalen, Betagalen Lotion
    • Denmark · Bekuval, Bemeson
    • Estonia · Betnovate
    • Spain · Betametasona Sonphar, Betnovate Crema
    • Finland · Bemetson, Betapred
    • France · Betamethasone Arrow, Betamethasone Biogaran
    • United Kingdom (Northern Ireland) · Audavate, Audavate Rd
    • Greece · Betnovate, Flogozyme
    • Croatia · Beloderm, Betamethasone Jgl
    • Hungary · Betesil
    • Ireland · Betacap Scalp Application, Betnovate
    • Iceland · Betnovat
    • Italy · Betamesol, Betametasone Dipropionato Sandoz
    • Lithuania · Celestoderm–v
    • Luxembourg · Betnelan V, Celestone
    • Latvia · Celestoderm-V
    • Malta · Betnovate
    • Netherlands · Betamethason Teva, Betamethason Xiromed
    • Norway · Betnovat, Diprotit
    • Portugal · Betametasona Basi, Betnovate
    • Romania · Betaderm, Betametazonă Fiterman
    • Sweden · Betametason Evolan, Betapred
    • Slovenia · Beloderm, Flosteron
    • Slovakia · Beloderm, Beloderm Lotion

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/b34cb5a2-4b61-453f-a5ea-a1bdf483a3cc
GET /v1/drugs/b34cb5a2-4b61-453f-a5ea-a1bdf483a3cc?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Maść",
  "source": "urpl",
  "strength": "0,5 mg/g",
  "packaging": "05909991565060 ¦ Rp ¦ 160444\n1 tuba 30 g",
  "substance": "Betamethasonum 0.5 mg/g",
  "common_name": "Betamethasonum",
  "pl_product_id": "100513133",
  "pozwolenie_nr": "054/25",
  "auth_procedure": "IR",
  "authorisation_validity": "2030-02-07"
}
    API referenceMCP serverPlans

    See everything about betamethasone.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console